{"id":63138,"date":"2026-05-20T19:03:01","date_gmt":"2026-05-20T17:03:01","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/insphero-ag-acquires-phenovista-biosciences-inc-to-expand-advanced-3d-cell-based-assay-capabilities\/"},"modified":"2026-05-20T19:03:01","modified_gmt":"2026-05-20T17:03:01","slug":"insphero-ag-acquires-phenovista-biosciences-inc-to-expand-advanced-3d-cell-based-assay-capabilities","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/insphero-ag-acquires-phenovista-biosciences-inc-to-expand-advanced-3d-cell-based-assay-capabilities\/","title":{"rendered":"InSphero AG Acquires PhenoVista Biosciences, Inc. to Expand Advanced 3D, Cell-based Assay Capabilities"},"content":{"rendered":"
\n

\nStrategic acquisition strengthens InSphero\u2019s global position as the market leader in predictive in vitro modeling and high-content imaging services<\/i><\/p>\n

<\/a>
<\/a><\/p>\n

SCHLIEREN, Switzerland & SAN DIEGO–(BUSINESS WIRE)–#Imaging<\/a>–InSphero AG, <\/b>a global leader in advanced 3D in vitro<\/i> models and services for drug safety and efficacy testing, today announced the acquisition of PhenoVista Biosciences, Inc., a premier provider of high-content imaging and phenotypic assay technologies based in San Diego, California.<\/p>\n

\nThe acquisition marks an important new chapter for PhenoVista Biosciences, enabling the company to significantly expand its scientific and commercial impact by combining its expertise in high-content imaging, cell painting, and phenotypic analysis with InSphero\u2019s globally recognized 3D microtissue platforms, AkuraFlow \u2122 microphysiological systems, and translational in vitro<\/i> technologies. Together, the combined organization aims to accelerate the adoption of more predictive, human-relevant drug discovery and toxicology workflows.<\/p>\n

\nOver the years, PhenoVista Biosciences has established a strong reputation for delivering high-quality, image-based assay development, advanced cellular analysis, and screening solutions to pharmaceutical and biotechnology customers. Through the integration into InSphero, PhenoVista gains access to a broader global commercial infrastructure, complementary biological platforms, and expanded operational capabilities globally.<\/p>\n

\n\u201cThe timing of this acquisition is particularly exciting given the accelerating momentum behind New Approach Methodologies in the United States. Recent policy initiatives and guidance from the U.S. Food and Drug Administration and growing investment support from the National Institutes of Health are creating a strong foundation for the broader adoption of human-relevant in vitro<\/i> technologies. Together with PhenoVista, we are exceptionally well positioned to support this transition with scalable, industry-ready solutions\u201d, says Jan Lichtenberg, CEO and Co-founder of InSphero AG.<\/p>\n

\n\u201cJoining forces with InSphero represents a highly exciting opportunity for PhenoVista, our employees, and our customers,\u201d said James G. Evans. \u201cBoth organizations share a strong commitment to advancing drug discovery through innovative assay technologies, advanced analytics, and artificial intelligence-driven approaches. By combining PhenoVista\u2019s strengths in high-content imaging and assay development with InSphero\u2019s leadership in scalable 3D biology and predictive in vitro<\/i> models, we can deliver even greater scientific value and broader capabilities to customers worldwide.\u201d<\/p>\n

\nThe combination is expected to create substantial opportunities across key therapeutic and translational research areas including oncology, fibrosis, neuroscience, and safety assessment. Customers will benefit from integrated workflows that combine advanced 3D biology, high-content imaging, and AI-enabled data analytics to generate richer and more predictive datasets earlier in the drug discovery process.<\/p>\n

\nThis expansion will enable faster turnaround times, closer customer collaboration, and improved access to advanced NAMs technologies in the rapidly growing in vitro market.<\/p>\n

\nAbout InSphero<\/b><\/p>\n

\nInSphero is the only 3D, in vitro<\/i> model company with the platform and expertise to modernize drug discovery in a way that empowers researchers to reach their full potential. Our innovative spheroid-based models allow for more effective and safe therapies to get to the clinic faster due to our superior robustness, reliability, reproducibility, and scalability. InSphero\u2019s goal is to inspire the next generation of breakthrough therapies through customer engagement, commitment to innovation, and the model of excellence.<\/p>\n

\nAbout PhenoVista Biosciences<\/b><\/p>\n

\nPhenoVista is a contract research organization (CRO) and leading provider of both custom and off-the-shelf, imaging-based assay services based in San Diego, California. They develop and execute disease-relevant, cell-based assays by working with clients in a collaborative, adaptable manner. PhenoVista provides high-quality data to biopharmaceutical clients of all stages and sizes with its unique combination of cutting-edge cell models and the latest high-content imaging technologies and data-analysis capabilities. Their diverse repertoire includes working with primary cells, iPSC-derived neurons and glia, and client-engineered lines in a variety of formats.<\/p>\n

Contacts<\/b> <\/p>\n

\nMedia Contacts:<\/b>
PhenoVista<\/span>
Ana Wang, Ph.D.
\n
Associate Director, BD & Marketing
\n
ana@phenovista.com<\/a><\/p>\n

\nInSphero<\/span>
Rositsa Hadzhipetrova, M.Sc.
\n
Head of Marketing
\n
rositsa.hadzhipetrova@insphero.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Strategic acquisition strengthens InSphero\u2019s global position as the market leader in predictive in vitro modeling and high-content imaging services SCHLIEREN, Switzerland & SAN DIEGO–(BUSINESS WIRE)–#Imaging–InSphero AG, a global leader in advanced 3D in vitro models and services for drug safety and efficacy testing, today announced the acquisition of PhenoVista Biosciences, Inc., a premier provider of … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-63138","6":"format-standard","7":"category-industry"},"yoast_head":"\nInSphero AG Acquires PhenoVista Biosciences, Inc. to Expand Advanced 3D, Cell-based Assay Capabilities - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/insphero-ag-acquires-phenovista-biosciences-inc-to-expand-advanced-3d-cell-based-assay-capabilities\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"InSphero AG Acquires PhenoVista Biosciences, Inc. to Expand Advanced 3D, Cell-based Assay Capabilities - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Strategic acquisition strengthens InSphero\u2019s global position as the market leader in predictive in vitro modeling and high-content imaging services SCHLIEREN, Switzerland & SAN DIEGO–(BUSINESS WIRE)–#Imaging–InSphero AG, a global leader in advanced 3D in vitro models and services for drug safety and efficacy testing, today announced the acquisition of PhenoVista Biosciences, Inc., a premier provider of ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/insphero-ag-acquires-phenovista-biosciences-inc-to-expand-advanced-3d-cell-based-assay-capabilities\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-20T17:03:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20260520349567\/en\/2811202\/22\/pv-logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/insphero-ag-acquires-phenovista-biosciences-inc-to-expand-advanced-3d-cell-based-assay-capabilities\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/insphero-ag-acquires-phenovista-biosciences-inc-to-expand-advanced-3d-cell-based-assay-capabilities\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"InSphero AG Acquires PhenoVista Biosciences, Inc. to Expand Advanced 3D, Cell-based Assay Capabilities\",\"datePublished\":\"2026-05-20T17:03:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/insphero-ag-acquires-phenovista-biosciences-inc-to-expand-advanced-3d-cell-based-assay-capabilities\\\/\"},\"wordCount\":633,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/insphero-ag-acquires-phenovista-biosciences-inc-to-expand-advanced-3d-cell-based-assay-capabilities\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260520349567\\\/en\\\/2811202\\\/22\\\/pv-logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/insphero-ag-acquires-phenovista-biosciences-inc-to-expand-advanced-3d-cell-based-assay-capabilities\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/insphero-ag-acquires-phenovista-biosciences-inc-to-expand-advanced-3d-cell-based-assay-capabilities\\\/\",\"name\":\"InSphero AG Acquires PhenoVista Biosciences, Inc. to Expand Advanced 3D, Cell-based Assay Capabilities - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/insphero-ag-acquires-phenovista-biosciences-inc-to-expand-advanced-3d-cell-based-assay-capabilities\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/insphero-ag-acquires-phenovista-biosciences-inc-to-expand-advanced-3d-cell-based-assay-capabilities\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260520349567\\\/en\\\/2811202\\\/22\\\/pv-logo.jpg\",\"datePublished\":\"2026-05-20T17:03:01+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/insphero-ag-acquires-phenovista-biosciences-inc-to-expand-advanced-3d-cell-based-assay-capabilities\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/insphero-ag-acquires-phenovista-biosciences-inc-to-expand-advanced-3d-cell-based-assay-capabilities\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/insphero-ag-acquires-phenovista-biosciences-inc-to-expand-advanced-3d-cell-based-assay-capabilities\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260520349567\\\/en\\\/2811202\\\/22\\\/pv-logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260520349567\\\/en\\\/2811202\\\/22\\\/pv-logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/insphero-ag-acquires-phenovista-biosciences-inc-to-expand-advanced-3d-cell-based-assay-capabilities\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"InSphero AG Acquires PhenoVista Biosciences, Inc. to Expand Advanced 3D, Cell-based Assay Capabilities\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"InSphero AG Acquires PhenoVista Biosciences, Inc. to Expand Advanced 3D, Cell-based Assay Capabilities - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/insphero-ag-acquires-phenovista-biosciences-inc-to-expand-advanced-3d-cell-based-assay-capabilities\/","og_locale":"en_US","og_type":"article","og_title":"InSphero AG Acquires PhenoVista Biosciences, Inc. to Expand Advanced 3D, Cell-based Assay Capabilities - Pharma Trend","og_description":"Strategic acquisition strengthens InSphero\u2019s global position as the market leader in predictive in vitro modeling and high-content imaging services SCHLIEREN, Switzerland & SAN DIEGO–(BUSINESS WIRE)–#Imaging–InSphero AG, a global leader in advanced 3D in vitro models and services for drug safety and efficacy testing, today announced the acquisition of PhenoVista Biosciences, Inc., a premier provider of ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/insphero-ag-acquires-phenovista-biosciences-inc-to-expand-advanced-3d-cell-based-assay-capabilities\/","og_site_name":"Pharma Trend","article_published_time":"2026-05-20T17:03:01+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20260520349567\/en\/2811202\/22\/pv-logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/insphero-ag-acquires-phenovista-biosciences-inc-to-expand-advanced-3d-cell-based-assay-capabilities\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/insphero-ag-acquires-phenovista-biosciences-inc-to-expand-advanced-3d-cell-based-assay-capabilities\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"InSphero AG Acquires PhenoVista Biosciences, Inc. to Expand Advanced 3D, Cell-based Assay Capabilities","datePublished":"2026-05-20T17:03:01+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/insphero-ag-acquires-phenovista-biosciences-inc-to-expand-advanced-3d-cell-based-assay-capabilities\/"},"wordCount":633,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/insphero-ag-acquires-phenovista-biosciences-inc-to-expand-advanced-3d-cell-based-assay-capabilities\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20260520349567\/en\/2811202\/22\/pv-logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/insphero-ag-acquires-phenovista-biosciences-inc-to-expand-advanced-3d-cell-based-assay-capabilities\/","url":"https:\/\/pharma-trend.com\/en\/insphero-ag-acquires-phenovista-biosciences-inc-to-expand-advanced-3d-cell-based-assay-capabilities\/","name":"InSphero AG Acquires PhenoVista Biosciences, Inc. to Expand Advanced 3D, Cell-based Assay Capabilities - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/insphero-ag-acquires-phenovista-biosciences-inc-to-expand-advanced-3d-cell-based-assay-capabilities\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/insphero-ag-acquires-phenovista-biosciences-inc-to-expand-advanced-3d-cell-based-assay-capabilities\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20260520349567\/en\/2811202\/22\/pv-logo.jpg","datePublished":"2026-05-20T17:03:01+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/insphero-ag-acquires-phenovista-biosciences-inc-to-expand-advanced-3d-cell-based-assay-capabilities\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/insphero-ag-acquires-phenovista-biosciences-inc-to-expand-advanced-3d-cell-based-assay-capabilities\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/insphero-ag-acquires-phenovista-biosciences-inc-to-expand-advanced-3d-cell-based-assay-capabilities\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20260520349567\/en\/2811202\/22\/pv-logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20260520349567\/en\/2811202\/22\/pv-logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/insphero-ag-acquires-phenovista-biosciences-inc-to-expand-advanced-3d-cell-based-assay-capabilities\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"InSphero AG Acquires PhenoVista Biosciences, Inc. to Expand Advanced 3D, Cell-based Assay Capabilities"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/63138","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=63138"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/63138\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=63138"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=63138"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=63138"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}